title: Re: Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study.
authors: Urology Service, Hospital Edouard Herriot, Lyon, France. Electronic address: marc.colombel@chu-lyon.fr.
authors: Marc C
authors: MC
authors: Colombel
mesh_terms: D000276:Adjuvants, Immunologic; D000283:Administration, Intravesical; D001500:BCG Vaccine; D001407:Bacillus; D015251:Epirubicin; D006801:Humans; D009364:Neoplasm Recurrence, Local; D001743:Urinary Bladder; D001749:Urinary Bladder Neoplasms
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D015251:Epirubicin